
Covet Biotech Private Limited
About Covet Biotech Private Limited
Data last updated:
Covet Biotech Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 May 2002 and has been in existence for over 24 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2002PTC017612. Its GSTIN is 08AACCC0398J1ZI (Rajasthan).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Karan Bhargava and Manas Bhargava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jaipur, Rajasthan.
As per the financials filed for FY 2024, the company reported a revenue of ₹47.46 Lakh, a growth of 71% compared to the previous year. For the same year it recorded a net loss of ₹5,021 (net margin -0.1%) and EBITDA of ₹48,187 (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 19% over five years.
As per MCA filings, the company has satisfied charges of ₹5.68 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Covet Biotech Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 35 Nu – Light Tonk Road, Gopalpura, Jaipur, Rajasthan, India – 302018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Covet Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Covet Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Covet Biotech Private Limited, buy the company report.
Financials of Covet Biotech Private Limited
FY 2025 filings availableCovet Biotech Private Limited reported revenue of ₹47.46 Lakh (up 71% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 71% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48,187 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5,021 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Covet Biotech Private Limited, buy the company report.
Board of directors of Covet Biotech Private Limited
Covet Biotech has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karan Bhargava | Director | 06 Feb 2017 | 9 Years 8 Months | Current |
| Manas Bhargava | Director | 20 Apr 2021 | 5 Years 6 Months | Current |
| Virendra Nath Bhargava Also directs: Compendium Pharmaceuticals Private Limited | Director | 08 May 2002 | 24 Years 5 Months | Current |
Peer comparison
Covet Biotech Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Riken Pharmaceuticals Private Limited | ₹47.58 Lakh (FY 2025) | 8.0% | Delhi, India | |||
| Bharatam Jayate Pharmacy Private Limited | ₹47.57 Lakh (FY 2024) | 23267.0% | Chandigarh, India | |||
| Covet Biotech Private Limitedthis company | ₹47.46 Lakh (FY 2024) | -₹5,021 | -0.1% | 71.0% | Jaipur, Rajasthan, India | |
| Growmed Lifesciences Private Limited | ₹47.37 Lakh (FY 2024) | 9.0% | Lucknow, Uttar Pradesh, India | |||
| Corden Pharma Private Limited | ₹47.14 Lakh (FY 2023) | -15.0% | Mumbai, Maharashtra, India | |||
| Inverse Pharmaceuticals Private Limited | ₹47.09 Lakh (FY 2023) | 42.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Covet Biotech Private Limited, buy the company report.
Auditor
Covet Biotech Private Limited is audited by SHAH PATNI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH PATNI & CO. | FY 2023 | 001055C |
Shareholding
The shareholding of Covet Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Covet Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 May 2017 | 100291218 | Others | ₹5.68 Lakh | Satisfied |
To see the full charge records of Covet Biotech Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Covet Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Covet Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Covet Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AACCC0398J1ZI | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Covet Biotech Private Limited, buy the company report.
Recent activity
Covet Biotech Private Limited has 6 board changes on record since 2002: 3 appointments and 3 cessations. The latest: Manas Bhargava was appointed as Director on 20 Apr 2021.
Frequently asked questions
Covet Biotech is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 May 2002 (24+ years old) and is registered under CIN U24232RJ2002PTC017612.
Covet Biotech has 3 current directors:
- Karan Bhargava - Director
- Manas Bhargava - Director
- Virendra Nath Bhargava - Director
The latest financial statements of Covet Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Covet Biotech is 08AACCC0398J1ZI, registered in Rajasthan.
The CIN (Corporate Identification Number) of Covet Biotech is U24232RJ2002PTC017612. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Covet Biotech was incorporated on 08 May 2002, making it 24+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Covet Biotech by revenue are Riken Pharmaceuticals Private Limited, Bharatam Jayate Pharmacy Private Limited, Growmed Lifesciences Private Limited, Corden Pharma Private Limited, Inverse Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Manas Bhargava was appointed as Director on 20 Apr 2021. Shailendra Nath Bhargava ceased to be Director on 20 Apr 2021. Karan Bhargava ceased to be Additional Director on 30 Sep 2017. Covet Biotech has 6 board changes on record in total.
The registered office of Covet Biotech is at A – 35 Nu – Light Tonk Road, Gopalpura, Jaipur, Rajasthan, India – 302018.
Covet Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Covet Biotech has no open charges and satisfied charges of ₹5.68 Lakh as per latest MCA filings.

